Does palliative chemotherapy beyond three courses benefit patients with non-small-cell lung cancer?

Affiliations

Comment

Cesare Gridelli. Nat Clin Pract Oncol. 2007 May.

. 2007 May;4(5):274-5.

doi: 10.1038/ncponc0776. Epub 2007 Mar 13.

¹ Division of Medical Oncology, SG Moscati Hospital, Contrada Amoretta, Italy. cgridelli@libero.it

No abstract available

Comment on

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.
von Plessen C, Bergman B, Andresen O, Bremnes RM, Sundstrom S, Gilleryd M, Stephens R, Vilsvik J, Aasebo U, Sorenson S. von Plessen C, et al. Br J Cancer. 2006 Oct 23;95(8):966-73. doi: 10.1038/sj.bjc.6603383. Epub 2006 Oct 3. Br J Cancer. 2006. PMID: 17047644 Free PMC article. Clinical Trial.